Advertisement

Overview of Synthetic and Modified Natural Bioactive Polymers

  • Charles G. Gebelein
  • Charles E. CarraherJr.
  • Van R. Foster
Part of the Polymer Science and Technology book series (PST, volume 38)

Abstract

The area of applied bioactive polymeric systems includes such diverse entities as controlled release systems (erodable systems, diffusion controlled systems, mechanical systems and microcapsules), and biologically active polymers, such as natural polymers, synthetic polypeptides, pseudo-enzymes, pseudo-nucleic acids and polymeric drugs. The area can also include immobilized bioactive materials, such as immobilized enzymes, antibodies and other bioactive agents and the area of artificial cells. This Chapter reviews the general field of biologically active synthetic and modified natural macro-molecules with an emphasis on their common characteristics, problems and applications. The areas reviewed include both medical and non-medical applications for both controlled release systems and polymers that exhibit direct biological activity.

Keywords

American Chemical Society Bioactive Material Bioactive Agent Dental Application Divinyl Ether 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    C. E. Carraher Jr. & C. G. Gebelein, Eds., “Biological Activities of Polymers”, American Chemical Society, Washington, DC, 1982.Google Scholar
  2. 2.
    C. G. Gebelein & C. E. Carraher Jr., Eds., “Bioactive Polymeric Systems”, Plenum Publ. Corp., New York, 1985.Google Scholar
  3. 3.
    C. G. Gebelein & C. E. Carraher Jr., Eds., “Polymeric Materials in Medication”, Plenum Publ. Corp., New York, 1985.Google Scholar
  4. 4.
    R. V. Petersen in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 151–177.CrossRefGoogle Scholar
  5. 5.
    J. Samanen in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 279–344.CrossRefGoogle Scholar
  6. 6.
    J. M. Whiteley in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 345–363.CrossRefGoogle Scholar
  7. 7.
    R. L. Juliano, Ed., “Biological Approaches to the Controlled Delivery of Drugs”, Vol. 507, New York Academy of Science, New York, 1987Google Scholar
  8. 8.
    I. V. Yannas, D. P. Orgill, E. M. Skrabut & J. F. Burke in: “Polymeric Materials and Artificial Organs”, C. G. Gebelein, Ed., ACS Symposium Series No. 256, American Chemical Society, Washington, DC, 1984, pp. 191–197.CrossRefGoogle Scholar
  9. 9.
    C. E. Carraher Jr. & L. H. Sperling, Polymer News, 13, 101–106 (1988).Google Scholar
  10. 10.
    S. D. Bruck, Ed., “Controlled Drug Delivery”, Vol. I, II, CRC Press, Boca Raton, FL (1983).Google Scholar
  11. 11.
    A. F. Kydonieus, “Controlled Release Technologies, Methods, Theory and Applications”, Vol. I, II, CRC Press, Boca Raton, FL (1980).Google Scholar
  12. 12.
    R. Kulkarni, K. Pani, C. Neuman & F. Leonard, “Poly(Lactic Acid) for Surgical Implants”, Tech. Report 6608, Walter Reed Medical Center, Washington, DC (1966).Google Scholar
  13. 13.
    D. A. Blake, S. Yolles, M. Helrich, H. F. Cascorbi & M. J. Eagan, Acad. Pharm. Sci., San Francisco, March 30, 1971.Google Scholar
  14. 14.
    J. Woodland, S. Yolles, D. Blake, M. Helrich & F. J. Meyer, J. Med. Chem., 16, 97 (1973).CrossRefGoogle Scholar
  15. 15.
    T. Jackanicz, H. Nash, D. Wise & J. B. Gregory, Contraception, 8, 227 (1973).CrossRefGoogle Scholar
  16. 16.
    A. Schindler, R. Jeffcoat, G. Kimmel, C. G. Pitt, M. E. Wall & R. Zweidinger in: “Contemporary Topics in Polymer Science”, E. M. Pearce & J. Schaefaer, Eds., Vol. 2, Plenum Publ. Corp., New York, 1977, p. 251.CrossRefGoogle Scholar
  17. 17.
    M. C. Bissen & F. Puisieux, “Proc. Ninth Internat. Symp. Controlled Release of Bioactive Materials”, Controlled Release Society, Ft. Lauderdale, FL, 1982, p. 30.Google Scholar
  18. 18.
    S. Mitra, M. Van Dress, J. Anderson, R. V. Petersen, D. Gregonis & J. Feijen, Polymer Preprints, 20 (2), 32 (1979).Google Scholar
  19. 19.
    N. S. Mason, C. S. Miles & R. E. Sparks, in: “Biomedical and Dental Applications of Polymers”, C. G. Gebelein & F. F. Koblitz, Eds., pp. 279–291, Plenum Publ., New York (1981).Google Scholar
  20. 20.
    J. J. L’Italien, Ed., “Proteins: Structure and Function”, Plenum Publ., New York, 1988.Google Scholar
  21. 21.
    C. H. Li, Ed., “Hormonal Proteins and Peptides”, Vol. 8, Academic Press, New York (1980).Google Scholar
  22. 22.
    J. Ramachandran, in: “Biological Activities of Polymers”, C. E. Carraher Jr. & C. G. Gebelein, Eds., pp. 119–132, American Chemical Society, Washington, DC (1982).CrossRefGoogle Scholar
  23. 23.
    Y. W. Chien, “Novel Drug Delivery Systems”, Dekker, New York, 1982.Google Scholar
  24. 24.
    J. R. Robinson & V. H. L. Lee, “Controlled Drug Delivery”, Dekker, New York, 1987.Google Scholar
  25. 25.
    N. F. Cardarelli & B. M Cardarelli in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 31–92.CrossRefGoogle Scholar
  26. 26.
    C. G. Pitt, T. A. Marks & A. Schindler, in: “Controlled Release of Bioactive Materials”, R. Baker, Ed., pp. 19–43, Academic Press, New York (1980).CrossRefGoogle Scholar
  27. 27.
    J. Heller & R. Baker, in: “Controlled Release of Bioactive Materials”, R. Baker, Ed., pp. 1–17, Academic Press, New York (1980).CrossRefGoogle Scholar
  28. 28.
    S. Yolles, R. M. Roat, M. F. Sartori & C. L. Washburne, in: “Biological Activities of Polymers”, C. E. Carraher Jr. & C. G. Gebelein, Eds., pp. 233–241, American Chemical Society, Washington, DC (1982).CrossRefGoogle Scholar
  29. 29.
    W. R. Good & K. F. Mueller, in: “Controlled Release of Bioactive Materials”, R. Baker, Ed., pp. 155–175, Academic Press, New York (1980).CrossRefGoogle Scholar
  30. 30.
    W. D. Rhine, V. Sukhatme, D. S. T. Hsieh & R. S. Langer, in: “Controlled Release of Bioactive Materials”, R. Baker, Ed., pp. 177–187, Academic Press, New York (1980).CrossRefGoogle Scholar
  31. 31.
    J. Feijen, D. Gregonis, C. Anderson, R. V. Petersen & J. Anderson, J. Pharm. Sci., 69, 871 (1980).CrossRefGoogle Scholar
  32. 32.
    D. Gregonis, J. Feijen, J. Anderson & R. V. Petersen, Polymer Preprints, 20 (1), 612 (1979).Google Scholar
  33. 33.
    W. A. R. Van Heeswijk, G. Brinks & J. Feijen, “Preprints Internat. Symposium on Polymers in Medicine”, Porto Cervo, Sardinia, Italy, 1982, p. 6.Google Scholar
  34. 34.
    R. V. Petersen, S. W. Kim, J. Anderson, S. Fang, D. G. Gregonis, J. Nelson, D. Coleman, S. Woodward & C. Anderson, “Development and Testing of New Biodegradable Drug Delivery Systems”, Contract No. 1-HD-2824, Final Report NICHD, (Dec. 14, 1980), p. 1.Google Scholar
  35. 35.
    A. Zaffaroni, in: “Biomedical and Dental Applications of Polymers”, C. G. Gebelein & F. F. Koblitz, Eds., pp. 293–313, Plenum Publ., New York (1981).Google Scholar
  36. 36.
    A. Zaffaroni, Chemtech, 6, 756–761 (1976).Google Scholar
  37. 37.
    G. W. Duncan, D. R. Kalkwarf & J. T. Veal, in: “Polymers in Medicine and Surgery”, R. L. Kronenthal, Z. Oser & E. Martin, Eds., pp. 205–212, Plenum Publ., New York (1975).CrossRefGoogle Scholar
  38. 38.
    S. Yolles, in: “Polymers in Medicine and Surgery 1’”, R. L. Kronenthal, Z. Oser & E. Martin, Eds., pp. 245–261, Plenum Publ., New York (1975).CrossRefGoogle Scholar
  39. 39.
    D. L. Gardner & B. A. Metz in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 93–119.CrossRefGoogle Scholar
  40. 40.
    J. V. Santiago, A. H. Clemens, W. L. Clarke & D. M. Kipnis, Diabetes, 28 (1), 71–84 (1979).Google Scholar
  41. 41.
    H. J. Sanders, Chem. Eng. News, Mar. 2, 1981, pp. 30–45.CrossRefGoogle Scholar
  42. 42.
    Y. W. Chien in: “Polymeric Materials in Medication”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 27–46.Google Scholar
  43. 43.
    W. R. Vieth, “Membrane Systems: Analysis and Design”, Oxford University Press, New York, 1988.Google Scholar
  44. 44.
    F. Theeuwes & B. Eckenhoff, in: “Controlled Release of Bioactive Materials”, R. Baker, Ed., pp. 61–82, Academic Press, New York (1980).CrossRefGoogle Scholar
  45. 45.
    E. R. Edelman, L. Brown, J. Taylor & R. Langer, J. Biomed. Mater. Res., 21, 339 (1987).CrossRefGoogle Scholar
  46. 46.
    S. K. Chandrasekaran & J. E. Shaw, in: “Controlled Release of Bioactive Materials”, R. Baker, Ed., pp. 99–106, Academic Press, New York (1980).CrossRefGoogle Scholar
  47. 47.
    D. A. Jones, Ed., “Transdermal & Related Drug Delivery Systems”, Noyes Data Corp., Park Ridge, NJ, 1984.Google Scholar
  48. 48.
    B. Sedlácek & J. Kahovec, Eds., “Synthetic Polymeric Membranes”, de Gruyter, New York, 1987.Google Scholar
  49. 49.
    P. Guiot & P. Couvreur, Eds., “Polymeric Nanoparticles and Microspheres”, CRC Press, Boca Raton, 1986.Google Scholar
  50. 50.
    A. Rembaum & Z. A. Tokes, Eds., “Microspheres: Medical and Biological Applications”, CRC Press, Boca Raton, 1988.Google Scholar
  51. 51.
    J. A. Bakan, in: “Polymers in Medicine and Surgery”, R. L. Kronenthal, Z. Oser & E. Martin, Eds., pp. 213–235, Plenum Publ., New York (1975).CrossRefGoogle Scholar
  52. 52.
    F. Lim & A. M. Sun, Science, 210, 980 (1980).CrossRefGoogle Scholar
  53. 53.
    T. Kondo, in: “Surface and Colloid Science”, E. Matijevic, Ed., Vol. 10, pp. 1–43, Plenum Publ., New York (1978).CrossRefGoogle Scholar
  54. 54.
    T. M. S. Chang, Ed., “Artificial Kidney, Artificial Liver, and Artificial Cells”, Plenum Publ., New York (1978).Google Scholar
  55. 55.
    T. M. S. Chang, in: “Biomedical Polymers. Polymeric Materials and Pharmaceuticals for Biomedical Use”, E. P. Goldberg & A. Nakajima, Eds., pp. 171–187, Academic Press, New York (1980).Google Scholar
  56. 56.
    A. Kato & T. Kondo in: “Advances in Biomedical Polymers”, C. G. Gebelein, Ed., Plenum Publ., New York, 1987, pp. 299–310.CrossRefGoogle Scholar
  57. 57.
    Anon. Polymer News, 13, 114–115 (1988)Google Scholar
  58. 58.
    C. H. Li, Ed., “Hormonal Proteins and Peptides”, Vol. I & II, Academic Press, New York (1973).Google Scholar
  59. 59.
    M. Ghosh, Polymer News, 13, 71–77 (1988).Google Scholar
  60. 60.
    A. G. Walton, in: “Biomedical Polymers. Polymeric Materials and Pharmaceuticals for Biomedical Use”, E. P. Goldberg & A. Nakajima, Eds., pp. 53–83, Academic Press, New York (1980).Google Scholar
  61. 61.
    J. M. Samanen in: “Polymeric Materials in Medication”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 227–247.Google Scholar
  62. 62.
    S. H. Snyder, Chem. Eng. News, Nov. 28, 1977, pp. 26–35.Google Scholar
  63. 63.
    J. A. Pavlisko & C. G. Overberger in: “Biomedical and Dental Applications of Polymers”, C. G. Gebelein & F. F. Koblitz, Eds., Plenum Publ. Corp., New York, 1981, p. 257.Google Scholar
  64. 64.
    A. S. Lindsey, in: “Reviews in Macromolecular Chemistry”, Vol. 4, G. B. Butler & K. F. O’Driscoll, Eds., pp. 1–47, Dekker, New York (1970).Google Scholar
  65. 65.
    Y. Imanishi, J. Polymer Sci., Macromol. Revs., 14, 1 (1979).CrossRefGoogle Scholar
  66. 66.
    Y. Imanishi in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 435–511.CrossRefGoogle Scholar
  67. 67.
    M. H. Keyes & S. Saraswathi in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 249–278.CrossRefGoogle Scholar
  68. 68.
    S. Saraswathi & M. S. Keyes in: “Polymeric Materials in Medication”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 249–264.Google Scholar
  69. 69.
    Anon., Chem. Week, July 6, 1988, p. 16.Google Scholar
  70. 70.
    H. B. Levy & T. Quinn in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 387–415.CrossRefGoogle Scholar
  71. 71.
    K. Takemoto, J. Polymer Sci., Poly. Symp., 55, 105 (1976).CrossRefGoogle Scholar
  72. 72.
    K. Takemoto in: “Polymeric Drugs”, L. G. Donaruma & O. Vogl, Eds., Academic Press, New York, 1978, p. 103.Google Scholar
  73. 73.
    K. Takemoto in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 417–433.CrossRefGoogle Scholar
  74. 74.
    J. Pitha, in: “Biomedical and Dental Applications of Polymers”, C. G. Gebelein & F. F. Koblitz, Eds., pp. 203–213, Plenum Publ., New York (1981).Google Scholar
  75. 75.
    J. Pitha, M. Akashi & M. Draminski, in: “Biomedical Polymers. Polymeric Materials and Pharmaceuticals for Biomedical Use”, E. P. Goldberg & A. Nakajima, Eds., pp. 271–297, Academic Press, New York (1980).Google Scholar
  76. 76.
    C. G. Gebelein, R. M. Morgan, R. Glowacky & W. Baig, in: “Biomedical and Dental Applications of Polymers”, C. G. Gebelein & F. F. Koblitz, Eds., pp. 191–201, Plenum Publ., New York (1981).Google Scholar
  77. 77.
    C. G. Gebelein, in: “Biological Activities of Polymers”, C. E. Carraher Jr. & C. G. Gebelein, Eds., pp. 193–203, American Chemical Society, Washington, DC (1982).CrossRefGoogle Scholar
  78. 78.
    J. L. Alderfer, R. E. Loomis, S. D. Soni, M. Sharma, R. Bernacki & R. Hughes Jr., in: “Polymeric Materials in Medication”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 125–138.Google Scholar
  79. 79.
    M. Ghosh & S. Haiti in: “Polymeric Materials in Medication”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 103–114.Google Scholar
  80. 80.
    C. Schuerch in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 365–386.CrossRefGoogle Scholar
  81. 81.
    J. F. Kennedy & N. R. Williams, Eds., “Carbohydrate Chemistry, A Review of the Literature”, Royal Society (London).Google Scholar
  82. 82.
    L. S. Goodman & A. Gilman, Eds., “The Pharmacological Basis of Therapeutics”, 4th, 5th & 6th Editions, Macmillan Co., New York, 1970, 1975, 1980.Google Scholar
  83. 83.
    A. Usmani & I. O. Salyer in: “Modifications of Polymers”, C. E. Carraher Jr. & J. Moore, Eds., Plenum Publ. Corp., New York, 1983, p. 247.Google Scholar
  84. 84.
    C. G. Gebelein, Polymer News, 4, 163–171 (1978).Google Scholar
  85. 85.
    L. G. Donaruma & O. Vogl, Eds., “Polymeric Drugs”, Academic Press, New York (1978).Google Scholar
  86. 86.
    L. G. Donaruma, R. M. Ottenbrite & O. Vogl, eds., “Anionic Polymeric Drugs”, Wiley-Interscience, New York (1980).Google Scholar
  87. 87.
    S. M. Samour, Chemtech, 8, 494–501 (1978).Google Scholar
  88. 88.
    H. Ringsdorf, J. Polymer Sci., Symposium No 51, 135–153 (1975).CrossRefGoogle Scholar
  89. 89.
    H. G. Batz, in: Advances in Polymer Science, Vol. 23, H. J. Cantrow, Ed., pp. 25–53, Springer-Verlag, New York (1977).Google Scholar
  90. 90.
    D. S. Breslow, Pure & Appl. Chem., 46, 103–113 (1976).CrossRefGoogle Scholar
  91. 91.
    V. A. Kropachev, Pure & Appl. Chem., 355–361 (1976).Google Scholar
  92. 92.
    R. M. Ottenbrite in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 513–529.CrossRefGoogle Scholar
  93. 93.
    K. Dorn, G. Hoerpel & H. Ringsdorf in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 531–585.CrossRefGoogle Scholar
  94. 94.
    G.B. Butler, in: “Anionic Polymeric Drugs”, L. G. Donaruma, R. M. Ottenbrite & O. Vogl, Eds., Wiley-Interscience, New York (1980), pp. 49–141.Google Scholar
  95. 95.
    L. G. Baird & A. M. Kaplan, in: “Anionic Polymeric Drugs”, L. G. Donaruma, R. M. Ottenbrite & O. Vogl, Eds., Wiley-Interscience, New York (1980), pp. 185–210.Google Scholar
  96. 96.
    M. C. Breinig, A. E. Munson & P. S. Morahan, in: “Anionic Polymeric Drugs”, L. G. Donaruma, R. M. Ottenbrite & O. Vogl, Eds., Wiley-Interscience, New York (1980), pp. 211–226.Google Scholar
  97. 97.
    E. M. Hodnett in: “Polymeric Materials in Medication”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 211–226.Google Scholar
  98. 98.
    C. E. Carraher Jr., W. S. Scott & D. J. Giron in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 587–620.CrossRefGoogle Scholar
  99. 99.
    M. J. Ostro, Ed., “Liposomes From Biophysics to Therapeutics”, Marcel Dekker, New York, 1987.Google Scholar
  100. 100.
    M. J. Ostro, Ed., “Liposomes”, Marcel Dekker, New York, 1983.Google Scholar
  101. 101.
    J. D. Rodwell, Ed., “Antibody-Mediated Delivery Systems”, Marcel Dekker, New York, 1988.Google Scholar
  102. 102.
    S. Ferrone & M. P. Dierich, Eds., “Handbook of Monoclonal Antibodies. Applications in Biology and Medicine”, Noyes Data Corp., Park Ridge, NJ, 1985.Google Scholar
  103. 103.
    C. E. Carraher in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ. Corp., New York, 1985, Chapters 20, 22.Google Scholar
  104. 104.
    A. Phillip, Prog. Org. Coatings, 2, 159 (1973/74).CrossRefGoogle Scholar
  105. 105.
    T. Hof, J. Inst. Wood Sci., 4, 19 (1969).Google Scholar
  106. 106.
    M. P. Levi, J. Inst. Wood Sci., 4, 45 (1969).Google Scholar
  107. 107.
    R. Cockroft, J. Inst. Wood Sci., 6, 2 (1974).Google Scholar
  108. 108.
    R. V. Subramanian, B. Gard, J. Jakubowski, J. Corredor, J. Montemarano & E. C. Fisher, Org. Coatings & Plastics Chem., 36 (2), 660 (1976).Google Scholar
  109. 109.
    R. V. Subramanian & M. Anand in: “Chemistry and Properties of Crosslinked Polymers”, S. S. Labana, Ed., Academic Press, New York, 1977, p. 1.CrossRefGoogle Scholar
  110. 110.
    R. V. Subramanian, B. K. Garg & J. Corredor, J. Macromol. Sci.-Chem., All, 1567 (1977).Google Scholar
  111. 111.
    R. V. Subramanian, B. K. Garg & J. Corredor in: “Organometallic Polymers”, C. E. Carraher Jr., J. Sheats & C. Pittman, Eds., Academic Press, New York, 1978, p. 181.Google Scholar
  112. 112.
    K. N. Somasekharan & R. V. Subramanian in: “Modification of Polymers”, C. E. Carraher Jr. & M. Tsuda, Eds., American Chemical Society, Washington, DC, 1980, p. 165.CrossRefGoogle Scholar
  113. 113.
    A. W. Sheldon, J. Paint Technol., 47 (600), 54 (1975).Google Scholar
  114. 114.
    E. J. Dyckman & J. A. Montemarano, “Antifouling Organometallic Polymers: Environmentally Compatible Materials”, NSRDC Report 4136, Feb. 1974.Google Scholar
  115. 115.
    H. B. Scher, “Controlled Release Pesticides”, American Chemical Society, Washington, DC, 1977.CrossRefGoogle Scholar
  116. 116.
    D. L. Gustafson in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 179–201.CrossRefGoogle Scholar
  117. 117.
    J. M. Miller & A. Yahiaoui in: “Bioactive Polymeric Systems”, C. G. Gebelein & C. E. Carraher Jr., Eds., Plenum Publ., New York, 1985, pp. 121–141.CrossRefGoogle Scholar
  118. 118.
    D. L. Wise, “Biopolymeric Controlled Release Systems”, Vol. II, CRC Press, Boca Raton, FL, 1984.Google Scholar
  119. 119.
    S. B. H. Kent in: “Biomedical Polymers”, E. Goldberg & A. Nakajima, Eds., Academic Press, New York, 1980, p. 213.Google Scholar
  120. 120.
    I. Chibati, “Immobilized Enzymes”, John Wiley & Sons, New York, 1978.Google Scholar
  121. 121.
    P. W. Carr & L. Bowers, “Immobilized Enzymes in Analytical and Clinical Chemistry”, John Wiley & Sons, New York, 1980.Google Scholar
  122. 122.
    A. I. Laskin, “Enzymes and Immobilized Cells in Biotechnology”, Butterworth Publ., Stonehan, MA, 1985.Google Scholar
  123. 123.
    R. A. Messing, Ed., “Immobilized Enzymes for Industrial Reactors”, Academic Press, New York, 1975.Google Scholar
  124. 124.
    H. H. Weetal, ed., “Immobilized Enzymes, Antigens, Antibodies and Peptides”, Dekker, New York (1975).Google Scholar
  125. 125.
    T. M. S. Chang, ed., “Biomedical Applications of Immobilized Enzymes and Proteins”, Vol. 1 & 2, Plenum Publ., New York (1977).Google Scholar
  126. 126.
    M. D. Trevan, “Immobilized Enzymes”, Wiley, New York (1980).Google Scholar
  127. 127.
    M. H. Keyes, in: “Kirk-Othmer, Encyclopedia of Chemical Technology”, 3rd. ed., Vol. 9, pp. 148–172, Wiley, New York (1980).Google Scholar
  128. 128.
    S. P. O’Neill, Rev. Pure & Appl. Chem., 22, 133–143 (1972).Google Scholar
  129. 129.
    T. Fujimura, F. Yoshii, I. Kaetsu, Y. Inoue & K. Shibata, Z. Naturforsch., 35c, 477–482 (1980).Google Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Charles G. Gebelein
    • 1
  • Charles E. CarraherJr.
    • 2
  • Van R. Foster
    • 3
  1. 1.Department of Chemistry Youngstown State UniversityYoungstownUSA
  2. 2.Department of ChemistryFlorida Atlantic UniversityBoca RatonUSA
  3. 3.DAP, Inc.DaytonUSA

Personalised recommendations